GLAM
AMED

Gardner Lewis Asset Management’s Amedisys AMED Stock Holding History

Gardner Lewis Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-52,099
Closed -$5.13M – 78
2025
Q2 		$5.13M Buy
+52,099
New +$4.93M 1.28% 32

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gardner Lewis Asset Management's AMED Position: Q3 2025 in Review

Gardner Lewis Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 52,099 shares — an estimated $5.13M sold.

Gardner Lewis Asset Management first reported a position in AMED in Q2 2025 and held it in 1 quarter. The position peaked at $5.13M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Gardner Lewis Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 52,099 Amedisys shares in Q3 2025, an estimated $5.13M.
  • Gardner Lewis Asset Management first reported a position in Amedisys in Q2 2025 and held it in 1 quarter.
  • Gardner Lewis Asset Management's Amedisys position peaked at $5.13M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Gardner Lewis Asset Management's 13F filing for Q3 2025, filed 10 Nov 2025.